Transforming Healthcare

In this episode of Transforming Healthcare, Dr. Bipin Patel is joined by Michael Makram Sadegh, Medical Advisor. Michael discusses cardiovascular care for women, including cultural pressures that lead women to neglect their health, and the gaps in research and diagnosis that disproportionately affect women.

Michael emphasises the importance of education and awareness in empowering women to take charge of their health, and he provides practical advice for women to advocate for themselves in healthcare settings. The conversation concludes with resources for further information and support.

Listen or download our podcast on the last Thursday of every month on all podcast channels.

Brought to you by⁠⁠ ⁠electronRx⁠

Follow us on⁠ LinkedIn.⁠

In this episode, Dr. Bipin Patel hosts Dr. Sameer Jamal, a cardiac electrophysiologist and assistant professor of medicine at Hackensack Meridian School of Medicine. They discuss the growing public health concern of atrial fibrillation (AFib), its impact on patients, and the critical role of early detection in improving outcomes.

Dr. Jamal highlights the latest advancements in AFib detection and treatment, from wearable technology to minimally invasive procedures like pulsed field ablation. The conversation also explores how healthcare providers, technology innovators, and the medical community can collaborate to identify and manage AFib before it leads to severe complications such as stroke and heart failure.

Listen or download our podcast on the last Thursday of every month on all podcast channels.

Brought to you by⁠⁠ electronRx

Follow us on LinkedIn.

In this conversation, Dr Bipin Patel interviews Cassie McGrath, a healthcare reporter for Morning Brew, discussing the current trends in healthcare, the impact of political changes on funding, and the innovations brought by AI and technology.

They explore the challenges and opportunities in healthcare technology, particularly focusing on the role of wearables and data privacy. The conversation highlights the importance of balancing technological advancements with accessibility and trust in the healthcare system.

Listen or download our podcast on the last Thursday of every month on all podcast channels.

Brought to you by⁠⁠ electronRx

Follow us on⁠ LinkedIn.

Note figure correction from Cassie: 68 of rural hospitals in the US are at risk of closing, 315 of which are at an “immediate risk.” Source: https://chqpr.org/downloads/Rural_Hospitals_at_Risk_of_Closing.pdf

In this conversation, Bipin Patel hosts Ghaith Sankari and Paula Salme Sandrak of Bayer to discuss the evolving landscape of Health AI and its differentiation from Digital Health. They explore the personalisation capabilities of AI solutions, the impact of clinical decision support tools, ethical considerations, regulatory challenges, and the future of AI in drug discovery. The discussion emphasises the importance of accessibility and equity in AI solutions while also highlighting the hidden potential of AI in healthcare.

Listen or download our podcast on the last Thursday of every month on all podcast channels.

Brought to you by⁠⁠ ⁠electronRx⁠⁠⁠

Follow us on⁠ ⁠⁠LinkedIn⁠

Statements made in the podcast represent -fully- the guests' personal perspectives and do not constitute or represent Bayer's official strategy, and this should be considered as an official disclaimer  . The comments we made about Bayer refer to publicly available information, and our perspectives on health AI are tied to our personal expertise.

In this episode, ⁠Dr Bipin Patel⁠ hosts Jose Maria (Chema) Guido Avila of Sanofi who discusses the importance of personalised patient experiences in the healthcare industry. He emphasises the need to understand patients as individuals rather than generic profiles, highlighting the significance of moments of truth in healthcare interactions.

Chema also explores the role of omni-channel marketing strategies in enhancing patient education and engagement, and the necessity of patient stratification to tailor information effectively. The two address the influence of Generation Z on healthcare decisions, noting their tendency to conduct extensive research before consulting healthcare professionals.

Listen or download our podcast on the last Thursday of every month on all podcast channels.

Brought to you by⁠⁠⁠ ⁠electronRx⁠⁠⁠⁠

Follow us on⁠⁠ ⁠⁠LinkedIn⁠⁠

In this special PharmaPod episode Dr Bipin Patel, CEO and founder of electronRx, and friends of the Clinical Trials industry explore the ways in which we can improve industry sustainability through a patient and technological inspired approach. For more information on the topics discussed be sure to read the Winter Issue of Journal for Clinical Studies, and click here for more on the NIHR Carbon Reduction Guidelines.

Listen or download our podcast on the last Thursday of every

Brought to you by⁠⁠ ⁠electronRx⁠⁠⁠

Follow us on⁠ ⁠⁠LinkedIn⁠

In this episode, ⁠Dr. Andy Potter⁠ ⁠(Whaddon Medical Centre⁠⁠) returns to discuss the challenges and management of asthma in primary care. He emphasises the critical role of accurate diagnosis and effective treatment in preventing exacerbations and hospitalisations.

Dr. Potter also addresses the barriers to effective asthma care, such as limited access to spirometry and skilled healthcare professionals. Alongside host ⁠Dr. Bipin Patel⁠, the two explore the complexities of asthma management, including the wide variety of inhalers and patients' attachment to their current inhalers.

Listen or download our podcast on the last Thursday of every month on all podcast channels.

Brought to you by⁠⁠ electronRx⁠⁠

Follow us on ⁠⁠LinkedIn

In this episode, Gerald and Maleen from PHA Europe join Dr Bipin Patel⁠⁠ to share their experiences with Pulmonary Arterial Hypertension (PAH). They discuss the challenges of getting an accurate diagnosis, the importance of early detection, and the emotional and physical impacts of living with this rare disease.

The dialogue emphasises the need for better communication between patients and healthcare providers, the role of technology in improving diagnosis and treatment, and the significance of advocacy and awareness in the PAH community. The discussion concludes with a call for collaboration between patients, healthcare professionals, and pharmaceutical companies to enhance the quality of life for those affected by PAH.

Listen or download our podcast on the last Thursday of every month on all podcast channels.

Brought to you by⁠⁠⁠⁠ electronRx⁠⁠⁠⁠

Follow us on ⁠⁠⁠⁠LinkedIn

In this bonus episode of Transforming Healthcare with ⁠electronRx⁠, we explore the complexities of interstitial lung disease drawing inspiration from our recent blog.

This umbrella term used to describe a group of highly variable restrictive lung diseases, characterised by inflammation and pulmonary fibrosis.

Treatment options include:

- Corticosteroids: Pfizer, Novartis, GSK, Merck, Astrazeneca

- Bronchodilators: AstraZeneca, GSK

- Antifibrotics: ⁠Roche⁠, ⁠Boehringer Ingelheim⁠

- Immunosuppressants: Astrellas, Sanofi, Bristol-Myers Squibb, Novartis, Roche⁠⁠

To read the full blog visit ⁠electronrx.com⁠

Brought to you by⁠⁠⁠⁠ electronRx⁠⁠⁠⁠

Follow us on ⁠⁠⁠⁠LinkedIn⁠

In this episode, Dr Bipin Patel sits down with Samuel Hollis, Country President and Managing Director at Novartis to explore the key elements of forming impactful healthcare partnerships.

Samuel shares his expertise on creating effective healthcare collaborations, emphasising on the importance of purpose-led partnerships, the role of digital tools, and the necessity of education in patient care. He also discusses the significance of data in healthcare, offers advice for startups looking to collaborate with pharma, and highlights the need for trust and shared goals in successful collaborations.

Listen or download our podcast on the last Thursday of every month on all podcast channels.

Brought to you by⁠⁠⁠ electronRx⁠⁠⁠

Follow us on ⁠⁠⁠LinkedIn